GSK-958108 is a serotonergic drug derived from the phenylpiperazine family which acts as a potent and selective 5-HT1A receptor antagonist, and has been researched as a potential treatment for sexual dysfunction.[1][2]

See also

References

  1. ↑ WO 2009/090202, Anderton CL, Woollam GR, "Monomaleate monohydrate salt of a 5ht1a receptor antagonist.", published 23 July 2009, assigned to Glaxo Group Ltd.
  2. ↑ Fiorino F, Severino B, Magli E, Ciano A, Caliendo G, Santagada V, et al. (June 2014). "5-HT(1A) receptor: an old target as a new attractive tool in drug discovery from central nervous system to cancer". Journal of Medicinal Chemistry. 57 (11): 4407–4426. doi:10.1021/jm400533t. PMID 24295064.
allikas: https://en.wikipedia.org/wiki/GSK-958108